ASX CODE: CYP

Cynata Therapeutics ASX CYP Celularity Cymerus

Cynata finds synergy with US-based biotech developer

Australian stem cell and regenerative medicine company Cynata Therapeutics (ASX: CYP) has signed a Memorandum of Understanding (MoU) with Celularity Inc., a US-based biotech...
Cynata Therapeutics ASX CYP clinical trial mesenchymal stem cells

Cynata Therapeutics advance to second cohort in stem cell trial

Stem cell and regenerative medicine company Cynata Therapeutics (ASX: CYP) has received an encouraging early response from the clinical trials of its stem cell...
Cynata Therapeutics CYP ASX clinical trial stem cell graft versus host disease

Cynata Therapeutics enrols first cohort for world first clinical trial

Stem cell and regenerative medicine company Cynata Therapeutics (ASX: CYP) has enrolled its first cohort for its “world first” clinical trial of its stem...

HOT TOPICS

TRENDING POSTS